Concepedia

Phase 2 Trial of Induction Gemcitabine, Oxaliplatin, and Cetuximab Followed by Selective Capecitabine-Based Chemoradiation in Patients With Borderline Resectable or Unresectable Locally Advanced Pancreatic Cancer

Nestor F. Esnaola, Uzair B. Chaudhary, Paul E. O’Brien, Elizabeth Garrett‐Mayer, E. Ramsay Camp, Melanie B. Thomas, David J. Cole, Alberto J. Montero, Brenda J. Hoffman, Joseph Romagnuolo,

International Journal of Radiation Oncology*Biology*Physics · 2014 · 49 citations · 17 references

DOI

Concepts

References

17

Cancer statistics, 2012

Rebecca L. Siegel, Deepa Naishadham, Ahmedin Jemal · CA A Cancer Journal for Clinicians · 2012 · 10.7K citations · Full text

, , +16

FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer

Thierry Conroy, Françoise Desseigne, Marc Ychou et al. · New England Journal of Medicine · 2011 · 7.8K citations · Full text

, , +13

Gemcitabine in Combination With Oxaliplatin Compared With Gemcitabine Alone in Locally Advanced or Metastatic Pancreatic Cancer: Results of a GERCOR and GISCAD Phase III Trial

Christophe Louvet, Roberto Labianca, Pascal Hammel et al. · Journal of Clinical Oncology · 2005 · 954 citations · Full text

, , +12

Pretreatment Assessment of Resectable and Borderline Resectable Pancreatic Cancer: Expert Consensus Statement

Mark P. Callery, Kenneth J. Chang, Elliot K. Fishman et al. · Annals of Surgical Oncology · 2009 · 898 citations

, , +16

Pancreatic cancer: a report of treatment and survival trends for 100,313 patients diagnosed from 1985–1995, using the National Cancer Database11No competing interests declared.

Stephen Sener, Amy M. Fremgen, Herman R. Menck et al. · Journal of the American College of Surgeons · 1999 · 793 citations

, , +11